Skip to content

Clinical trials

Recruiting Observational Smoldering Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Smoldering Multiple Myeloma Phase: Observational Status: Recruiting Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20182
20211
20222
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Azienda USL Reggio Emilia - IRCCS1
Dana-Farber Cancer Institute1
European Myeloma Network B.V.1
Fondazione IRCCS Policlinico San Matteo di Pavia1
Indiana University1
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1
Peking University First Hospital1
Tufts Medical Center1
UNC Lineberger Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Smoldering Multiple Myeloma14
Monoclonal Gammopathy of Undetermined Significance10
Multiple Myeloma8
Leukemia, Plasma Cell3
Amyloidosis2
Castleman Disease2
Cryoglobulinemia2
Immunoglobulin Light-chain Amyloidosis2
POEMS Syndrome2
Hematologic Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.